Beneficial effect of donor-specific blood transfusions (DST) on living-related kidney allograft survival.
The survival rate of 19 patients who underwent living-related kidney transplantation after donor-specific blood transfusions (DST) was compared with that of 32 historical controls receiving transplants without DST. The graft survival rate of the DST group was 82% after two and three years. The graft survival rate of the DST group was significantly better than the 53% rate after two years obtained with the 32 historical controls (p less than 0.05). We tested sera from 16 DST-treated recipients to study the beneficial effect of DST on kidney allograft survival using the mixed lymphocyte culture (MLC) serum inhibition test. The results demonstrated that MLC inhibitory factors were induced in the serum of the recipient after completion of DST. This inhibition of MLC was observed by treatment of responder lymphocytes with serum obtained three weeks after DST plus rabbit complement. The inhibitory effect was also specific for responder cells in anti-donor MLC. Regarding the correlation with rejection episodes, these MLC inhibitory factors were often observed in the non-rejection group (p less than 0.05). The data suggest that such factors may be anti-idiotypic antibodies and be associated with prolonged graft survival.
D000328:Adult; D000917:Antibody Formation; D001804:Blood Transfusion, Autologous / Q000379:methods*; D002102:Cadaver; D005219:Father-Child Relations; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006238:Haploidy; D006801:Humans; D016030:Kidney Transplantation; D007959:Lymphocyte Culture Test, Mixed / Q000379:methods; D008297:Male; D009034:Mother-Child Relations; D012801:Sibling Relations; D013997:Time Factors